Back to Journals » Infection and Drug Resistance » Volume 5

Infection and Drug Resistance


Archive: Volume 5, 2012

Current management options for latent tuberculosis: a review

Norton BL, Holland DP

Infection and Drug Resistance 2012, 5:163-173

Published Date: 29 November 2012

Adverse incidents resulting in exposure to body fluids at a UK dental teaching hospital over a 6-year period

Hughes A, Davies L, Hale R, Gallagher JE

Infection and Drug Resistance 2012, 5:155-161

Published Date: 25 October 2012

Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes

Marí Solivellas B, Cabanes Martín T

Infection and Drug Resistance 2012, 5:149-153

Published Date: 16 October 2012

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food

Tham J, Walder M, Melander E, Odenholt I

Infection and Drug Resistance 2012, 5:143-147

Published Date: 16 October 2012

Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance

Chen LF, Anderson DJ, Paterson DL

Infection and Drug Resistance 2012, 5:133-141

Published Date: 24 September 2012

Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection

Sarovich DS, Price EP, Limmathurotsakul D, Cook JM, Von Schulze AT, Wolken SR, Keim P, Peacock SJ, Pearson T

Infection and Drug Resistance 2012, 5:129-132

Published Date: 22 August 2012

Treatment of dengue fever

Rajapakse S, Rodrigo C, Rajapakse A

Infection and Drug Resistance 2012, 5:103-112

Published Date: 23 July 2012

Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB

Chaiyasirinroje B, Aung MN, Moolphate S, Kasetjaroen Y, Rienthong S, Rienthong D, Nampaisan O, Nedsuwan S, Sangchun W, Suriyon N, Mitarai S, Yamada N

Infection and Drug Resistance 2012, 5:79-86

Published Date: 7 May 2012

The effects of daily chlorhexidine bathing on cutaneous bacterial isolates: a pilot study

Soma VL, Qin X, Zhou C, Adler A, Berry JE, Zerr DM

Infection and Drug Resistance 2012, 5:75-78

Published Date: 24 April 2012

High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India

Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Stålsby Lundborg C

Infection and Drug Resistance 2012, 5:65-73

Published Date: 5 April 2012

Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine-pyrimethamine in Côte d’Ivoire

Offianan AT, Penali LK, Coulibaly MA, Tiacoh NL, Ako AAB, Adji EG, Coulibaly B, Koffi D, Sarr D, Jambou R, Kone M

Infection and Drug Resistance 2012, 5:53-63

Published Date: 12 March 2012

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia

Maselli DJ, Fernandez JF, Whong CY, Echevarria K, Nambiar AM, Anzueto A, Restrepo MI

Infection and Drug Resistance 2012, 5:43-51

Published Date: 1 February 2012

Conjunctival sac bacterial flora isolated prior to cataract surgery

Suto C, Morinaga M, Yagi T, Tsuji C, Toshida H

Infection and Drug Resistance 2012, 5:37-41

Published Date: 24 January 2012

Ceftaroline in complicated skin and skin-structure infections

Hernandez PO, Lema S, Tyring SK, Mendoza N

Infection and Drug Resistance 2012, 5:23-35

Published Date: 19 January 2012

Evaluation of the use of piperacillin/tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions?

Khan FY, Elhiday A, Khudair IF, Yousef H, Omran AH, Alsamman SH, Elhamid M

Infection and Drug Resistance 2012, 5:17-21

Published Date: 13 January 2012